Ioannis Kasouridis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ioannis Kasouridis has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Camelia Demetrescu
Department of Cardiology, Guy’s and St Thomas’ NHS Trust, London, UK
2 shared publications - Julia Grapsa
Department of Cardiology, Guys and St Thomas NHS Trust, London, UK
2 shared publications - Aditya Bhalla
Department of Cardiology, Guy’s and St Thomas’ NHS Trust, London, UK
1 shared publication - Ali Vazir
Department of Cardiology, Royal Brompton Hospital, London, UK
1 shared publication - Amedeo Chiribiri
Guy’s and St Thomas’ Hospital & School of Biomedical Engineering and Imaging Sciences, King’s College London Department of Cardiology Westminster Bridge Road, London SE1 7EH
1 shared publication Andrew L. Clark
University of Hull, Hull, UK
1 shared publication
Latest Publications
- Open Access
- 23 May 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20, e18
Sex Differences in Heart Failure: A Step Forward
Heart failure is a life-threatening condition that affects women and men differently. Due to increases in mean patient age, heart failure prevalence and mortality rates are expected to increase rapidly. Heart failure is characterised as a syndrome leading to a high burden of disease for the individual patient and increased healthcare costs for society related to rehospitalisation. This review highlights sex differences across the entire spectrum of heart failure.
- 23 May 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20, e18
Open AccessSex Differences in Heart Failure: A Step Forward
Heart failure is a life-threatening condition that affects women and men differently. Due to increases in mean patient age, heart failure prevalence and mortality rates are expected to increase rapidly. Heart failure is characterised as a syndrome leading to a high burden of disease for the individual patient and increased healthcare costs for society related to rehospitalisation. This review highlights sex differences across the entire spectrum of heart failure.
- Open Access
- 5 July 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 17, 101842
Endocarditis in ACHD, Be Aware, PREVENT, Diagnose Early and Treat
- 5 July 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 17, 101842
Open AccessEndocarditis in ACHD, Be Aware, PREVENT, Diagnose Early and Treat
- Open Access
- 18 November 2022
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 8, e31
Multimodality Imaging in Valvular Structural Interventions
Structural valvular interventions have skyrocketed in the past decade with new devices becoming available and indications for patients who would previously have been deemed inoperable. Furthermore, while echocardiography is the main imaging tool and the first line for patient screening, cardiac magnetic resonance and CT are now essential tools in pre-planning and post-procedural follow-up. This review aims to address imaging modalities and their scope in aortic, mitral and tricuspid structural valvular interventions, including multimodality imaging. Pulmonary valve procedures, which are mostly carried out in patients with congenital problems, are discussed. This article presents a guide on individualised imaging approaches on each of the available interventional procedures.
- 18 November 2022
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 8, e31
Open AccessMultimodality Imaging in Valvular Structural Interventions
Structural valvular interventions have skyrocketed in the past decade with new devices becoming available and indications for patients who would previously have been deemed inoperable. Furthermore, while echocardiography is the main imaging tool and the first line for patient screening, cardiac magnetic resonance and CT are now essential tools in pre-planning and post-procedural follow-up. This review aims to address imaging modalities and their scope in aortic, mitral and tricuspid structural valvular interventions, including multimodality imaging. Pulmonary valve procedures, which are mostly carried out in patients with congenital problems, are discussed. This article presents a guide on individualised imaging approaches on each of the available interventional procedures.
- 10 November 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (11) , e232057
Atypical marantic endocarditis
Marantic endocarditis is a rare non-infectious endocarditis that mostly affects the aortic and mitral valves. It is often an autopsy finding that is most commonly seen in advanced malignancies thought to be due to a hypercoagulable state. When diagnosed antemortem, it typically presents with signs and symptoms of embolisation. We report a case of a 44-year-old Caucasian man with marantic endocarditis secondary to metastatic small cell lung cancer. Our patient presented with a short history of lower back pain with no signs/symptoms of embolisation, and a pansystolic murmur on initial physical examination. Serial blood cultures were negative and transthoracic echocardiography revealed vegetation on the posterior leaflet of the mitral valve. Further imaging in the form of MRI spine and CT thorax/abdomen/pelvis showed pulmonary lesions with liver and bony metastasis. Subsequent image-guided biopsy confirmed metastatic small cell lung cancer of T1N2M1c grade, which was treated with palliative chemotherapy and radiotherapy.
- 10 November 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (11) , e232057
Atypical marantic endocarditis
Marantic endocarditis is a rare non-infectious endocarditis that mostly affects the aortic and mitral valves. It is often an autopsy finding that is most commonly seen in advanced malignancies thought to be due to a hypercoagulable state. When diagnosed antemortem, it typically presents with signs and symptoms of embolisation. We report a case of a 44-year-old Caucasian man with marantic endocarditis secondary to metastatic small cell lung cancer. Our patient presented with a short history of lower back pain with no signs/symptoms of embolisation, and a pansystolic murmur on initial physical examination. Serial blood cultures were negative and transthoracic echocardiography revealed vegetation on the posterior leaflet of the mitral valve. Further imaging in the form of MRI spine and CT thorax/abdomen/pelvis showed pulmonary lesions with liver and bony metastasis. Subsequent image-guided biopsy confirmed metastatic small cell lung cancer of T1N2M1c grade, which was treated with palliative chemotherapy and radiotherapy.
- 22 May 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Giant cell myocarditis presenting with acute heart failure
Idiopathic giant cell myocarditis (GCM) is a rare and rapidly progressing form of myocarditis predominantly affecting younger people. We report a case of a 23-year-old athletic patient who presented with features of acute heart failure due to GCM and discuss his management that included a left ventricular assist device as a bridge to transplant. He died immediately following the transplant. We also review the literature on this rare disease, highlighting the advances in the management of the disease including immunosuppressive therapy, ventricular assist devices and heart transplantation.
- 22 May 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Giant cell myocarditis presenting with acute heart failure
Idiopathic giant cell myocarditis (GCM) is a rare and rapidly progressing form of myocarditis predominantly affecting younger people. We report a case of a 23-year-old athletic patient who presented with features of acute heart failure due to GCM and discuss his management that included a left ventricular assist device as a bridge to transplant. He died immediately following the transplant. We also review the literature on this rare disease, highlighting the advances in the management of the disease including immunosuppressive therapy, ventricular assist devices and heart transplantation.